menu
    • menu

    Company profile for Clarity Pharmaceuticals

    NEW Drugs in Dev: 9
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Established in 2010, Clarity is a Sydney-based life sciences company that utilises its radio-pharmaceutical capability to produce safer and more effective medicines to improve patient outcomes. Clarity’s technology, developed in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) and the University of Melbourne, allows biopharmaceuticals to be radiolabelled for therapy as well as visualis...
    Established in 2010, Clarity is a Sydney-based life sciences company that utilises its radio-pharmaceutical capability to produce safer and more effective medicines to improve patient outcomes. Clarity’s technology, developed in collaboration with the Australian Nuclear Science and Technology Organisation (ANSTO) and the University of Melbourne, allows biopharmaceuticals to be radiolabelled for therapy as well as visualised using PET imaging. The imaging data generated provides powerful information on targeting, clearance and biodistribution of the product, which aids in drug development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clarity PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    National Innovation Centre, 4 Cornwallis Street, Sydney, NSW 2015, AU
    Telephone
    Telephone
    +61 (0)2 9209 4037
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.claritypharmaceuticals.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clarity-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clarity Inks Deal For Cu-64 Sar-Bispsma Manufacturing
    Clarity Inks Deal For Cu-64 Sar-Bispsma Manufacturing

    14 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clarity-signs-a-commercial-manufacturing-agreement-for-cu-64-sar-bispsma-with-nucleus-radiopharma-302741108.html

    PR NEWSWIRE
    14 Apr 2026
    Share Share
    Co-Psma Data Published In The European Urology Journal
    Co-Psma Data Published In The European Urology Journal

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/co-psma-data-published-in-the-european-urology-journal-302729404.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Clarity Inks Major Copper-64 Supply Deal With Theragenics
    Clarity Inks Major Copper-64 Supply Deal With Theragenics

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clarity-signs-a-large-scale-manufacturing-supply-agreement-for-copper-64-with-theragenics-302724207.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    Another SECuRE Participant with Undetectable PSA, Negative Biopsy
    Another SECuRE Participant with Undetectable PSA, Negative Biopsy

    23 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/secure-trial-update-another-participant-with-undetectable-psa--negative-psma-pet-302694256.html

    PR NEWSWIRE
    23 Feb 2026
    Share Share
    SECuRE Trial Proceeds Unchanged Post Safety Review Meeting
    SECuRE Trial Proceeds Unchanged Post Safety Review Meeting

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/secure-trial-to-continue-with-no-modifications-to-protocol-following-safety-review-committee-meeting-302661847.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share
    Clarity Signs Copper-67 Supply Agreement With Nusano
    Clarity Signs Copper-67 Supply Agreement With Nusano

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clarity-signs-copper-67-supply-agreement-with-nusano-302585704.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search